2025 Free

Closer to a Cure — 15 Years of Impact

Brain Tumour Research was founded in 2009 by families affected by brain tumours, with a mission to increase UK research investment and fund Centres of Excellence. Their 2025 impact report — marking 15 years — documents £46.4m contributed to the national research effort, five active Centres of Excellence, 260 research personnel supported, and major breakthroughs including an FDA-designated blood test for brain tumour detection and HIV drugs repurposed for schwannoma treatment.

Report snapshot
85 Views

About

Centres of Excellence at University of Plymouth, Imperial College London, Queen Mary University of London, Institute of Cancer Research (paediatric), Scottish Centre (Edinburgh/Glasgow); PRIME patient involvement programme, BTR-NTA therapeutics accelerator, BRAIN UK tissue bank Custom geography from upload: UK

Key Metrics

Key Metric 1 £23.2m awarded to research since 2009; £18.2m directly to Centres of Excellence; Centres leveraged additional £23.2m — total £46.4m contribution to national investment
Key Metric 2 5 Centres of Excellence funded across UK; 39 PhD students supported; 260 research personnel supported; 167 publications underpinned
Key Metric 3 130+ research projects supported through Funded Initiatives; 23 novel therapies reviewed by BTR-NTA; BRAIN UK tissue bank holds 210,000+ cases and has supplied 26,000+ samples to 110+ studies

Key Outcomes

  • Blood test for high-grade brain tumours granted FDA Breakthrough Device Designation (2023); Barts Brain Tumour Centre grew from zero clinical trials in 2019 to running the most brain tumour clinical trials of any UK neuro-oncology centre in 2024
  • Scottish Brain Tumour Research Centre launched January 2025 with £2.4m over five years; PRIME patient involvement initiative helped secure over £28m in brain tumour trial funding
  • National annual spend on brain tumours increased from under £4m in 2009 to over £17m; 140 global research group collaborations across 19 countries; HIV anti-retroviral RETREAT trial launched June 2024 for schwannoma/NF2 patients

Geography

UK-Wide

Impact Snapshot
Key Metric 1
Total income £18,180,000 and total expenditure £18,560,000 (year ended 31 December 2024, charity no. 1084958 England/Wales and SC039654 Scotland); in 2024 spent £3.8m on...
Key Metric 2
700+ members supported through in-person visits and support calls in 2025; 697 support grants allocated in 2025 for essential items including specialist clothing, cooling...
Key Metric 3
Largest global investment in EB research to date: multi-million-pound drug repurposing trial provisionally agreed with LifeArc partner at Guy's and St Thomas' NHS Foundation...
£34,000 raised in 2025 winter appeal supporting families like Darcie's with specialist items, emotional support and research; 697 support grants delivered in 2025; first Members Connect event in Northern Ireland; EB Priorities Setting Partnership study completed providing global research roadmap
Impact Snapshot
Key Metric 1
22,507 households helped through RBL casework and specialist support services across 66 countries
Key Metric 2
22,600 grants given to those in need, totalling £11.8 million
Key Metric 3
733 beneficiaries represented at tribunals, resulting in £24.5 million in War Pensions awards
1,548 new families living with dementia supported by RBL Admiral Nurses service
Impact Snapshot
Key Metric 1
3,600 blind veterans received support across the UK; 447 new blind veterans started receiving support in 2024/25
Key Metric 2
1,598 referrals to rehabilitation services completed; 313 veterans received assistive technology training
Key Metric 3
997 volunteers donated 26,824 hours of support; befriending service awarded Quality in Befriending Excellence — one of only 11 organisations in the UK to...
1,831 National Creative Wellbeing Project packs issued to help veterans reconnect with creativity and independence
Impact Snapshot
Key Metric 1
349,000+ people completed the Know Your Risk tool to assess their risk of type 2 diabetes in 2024
Key Metric 2
£4 million invested in 17 new research projects; total active grants portfolio worth over £45 million
Key Metric 3
32% of people completing NHS England's Path to Remission programme — which Diabetes UK campaigned for — put their type 2 diabetes into remission
Type 1 Diabetes Grand Challenge invested over £23 million in 19 projects across 161 experts from 47 institutions in 8 countries since 2022